Importantly, genetic signatures of γδ T cell infiltration or IL17 signaling in diagnostic biopsies from patients with 1,042 HR+HER2− breast cancer from the METABRIC dataset11 were associated with decreased disease-specific survival (DSS). This evidence concerns the gene ERBB2 and breast cancer.